SARS-CoV-2

A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease

Molnupiravir and COVID-19 Mortality Reduction in the Omicron Era

Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age

Efficacy and Safety of BIO101 in the Prevention of Respiratory Deterioration in Hospitalized COVID-19 Patients

Secondary Databased Post-marketing Surveillance Study of BNT162b2

A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

French Single Centre Experience of Critically Ill Patients With Covid 19

Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2

POC Performance Evaluation of LumiraDx SARS-CoV-2 Ag Ultra and SARS-CoV-2 & Flu A/B Tests.

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Combo Test

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital

Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases

Rutgers COVID-19 Cohort Study

Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation

Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)

Korea Comirnaty Post-marketing Surveillance

COVID-19 and ICU-acquired MDR Bacteria